Our results show that the diagnostic power (AUC) of the tested parameters, especially M-CSF, in the group of CC patients was marginally lower in comparison with the diagnostic power of M-CSF in the course of pancreatic cancer study conducted by Vasiliades et al. [34]. This evidence concerns the gene CSF1 and familial pancreatic carcinoma.